0000950123-18-001716.txt : 20180213
0000950123-18-001716.hdr.sgml : 20180213
20180213131931
ACCESSION NUMBER: 0000950123-18-001716
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20180213
DATE AS OF CHANGE: 20180213
EFFECTIVENESS DATE: 20180213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRV GP, LLC
CENTRAL INDEX KEY: 0001578973
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18416
FILM NUMBER: 18601671
BUSINESS ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001578973
XXXXXXXX
12-31-2017
12-31-2017
TRV GP, LLC
C/O THIRD ROCK VENTURES
29 Newbury Street, 3rd Floor
Boston
MA
02116
13F HOLDINGS REPORT
028-18416
N
Kevin Gillis
Chief Financial Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
02-13-2018
3
5
221278
false
1
Mark Levin
2
Kevin P. Starr
3
Robert I. Tepper
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
ELEVEN BIOTHERAPEUTICS, INC.
COM
286221106
3922
4841591
SH
DFND
1,2,3
4841591
0
0
ZAFGEN, INC.
COM
98885E103
972
210371
SH
DFND
1,2,3
210371
0
0
CYTOMX THERAPEUTICS, INC.
COM
23284F105
70093
3320348
SH
DFND
1,2,3
3320348
0
0
KALA PHARMACEUTICALS INC.
COM
483119103
30590
1654425
SH
DFND
1,2,3
1654425
0
0
RHYTHM PHARMACEUTICALS, INC.
COM
76243J105
115701
3981437
SH
DFND
1,2,3
3981437
0
0